Hydroxyurea-induced onychomadesis in a dog with chronic myeloid leukemia: A case report
Carregando...
Arquivos
Data
2018-09-01
Autores
Anjos, Denner Santos dos [UNESP]
Costa, Paula Barbosa
Magalhães, Larissa Fernandes
Sierra, Oscar Rodrigo [UNESP]
Calazans, Sabryna Gouveia
Fonseca-Alves, Carlos Eduardo [UNESP]
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
A 12-year-old Rottweiler dog was presented with a history of prostration, weight loss and hyporexia for six months. Based on complete blood tests (hematological and biochemical analyses), bone marrow examination and imaging analysis, a diagnosis of chronic myeloid leukemia was made. Treatment with hydroxyurea at a dosage of 18 mg/kg twice daily was not effective in controlling the high count of white blood cells. Furthermore, after 35 days of hydroxyurea treatment, the animal developed onycholysis, with sloughing of the claws of the left pelvic and left thoracic limbs and exposure of the distal phalanx. Interruption of the medication was implemented, with clinical healing of the ungual lesions observed three months after initiation of the drug. White blood cells returned to normal after using cyclophosphamide. Currently, the animal is in complete remission, having a disease-free interval of 575 days without chemotherapy. To the authors’ knowledge, this is the first report of hydroxyurea-induced onycholysis within a short-term period in a dog diagnosed with chronic myeloid leukemia.
Descrição
Palavras-chave
Canine, Hydroxycarbamide, Onycholysis
Como citar
Topics in Companion Animal Medicine, v. 33, n. 3, p. 73-76, 2018.